BNTC (Benitec Biopharma) Total Operating Expense: $46.60 Mil (TTM As of Mar. 2026)


BNTC Benitec Biopharma Inc BNTC
34 GF Score
Price $12.70
View Full Analysis

What is Benitec Biopharma Total Operating Expense?

Benitec Biopharma BNTC +2.83% 34 Total Operating Expense is $46.60 Mil as of Mar. 2026. GuruFocus rates BNTC with a GF Score™ of 34/100.

Benitec Biopharma's Total Operating Expense for the three months ended in Mar. 2026 was $13.58 Mil. Benitec Biopharma's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $46.60 Mil.

Benitec Biopharma Total Operating Expense Related Terms

Benitec Biopharma Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Benitec Biopharma's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma Total Operating Expense Chart

Benitec Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.53 17.92 19.16 22.49 41.77

Benitec Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.34 9.83 9.80 13.38 13.58
BNTC
34GF Score
Benitec Biopharma Inc BNTC
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $46.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $46.60 Mil mean?
Benitec Biopharma (BNTC) has a Total Operating Expense of $46.60 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Benitec Biopharma and its competitors.
Is Benitec Biopharma's Total Operating Expense too high?
Benitec Biopharma's current Total Operating Expense is $46.60 Mil. Overall, Benitec Biopharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Benitec Biopharma's Total Operating Expense compare to IPSC and FBRX?
Benitec Biopharma's Total Operating Expense of $46.60 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Benitec Biopharma and its competitors. Benitec Biopharma's current Total Operating Expense is $46.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Benitec Biopharma stock overvalued right now?
Benitec Biopharma (BNTC) has a current Total Operating Expense of $46.60 Mil. The current Total Operating Expense is $46.60 Mil. Benitec Biopharma's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Benitec Biopharma (BNTC), the current Total Operating Expense is $46.60 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for BNTC

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.70
Price